Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients

NCT02694224 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: vismodegib
DRUG: Paclitaxel
DRUG: Epirubicin
DRUG: Cyclophosphamide

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra